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In the recent years thousands of non-coding RNAs have been identified, also thanks
to highthroughput sequencing technologies. Among them, circular RNAs (circRNAs)
are a well-represented class characterized by the high sequence conservation and cell
type specific expression in eukaryotes. They are covalently closed loops formed through
back-splicing. Recently, circRNAs were shown to regulate a variety of cellular processes
functioning as miRNA sponges, RBP binding molecules, transcriptional regulators,
scaffold for protein translation, as well as immune regulators. A growing number of
studies are showing that deregulated expression of circRNAs plays important and
decisive actions during the development of several human diseases, including cancer.
The research on their biogenesis and on the various molecular mechanisms in which
they are involved is going very fast, however, there are still few studies that address
their involvement in embryogenesis and eukaryotic development. This review has the
intent to describe the most recent progress in the study of the biogenesis and molecular
activities of circRNAs providing insightful information in the field of embryogenesis and
cell differentiation. In addition, we describe the latest research on circRNAs as novel
promising biomarkers in diverse types of tumors.
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INTRODUCTION
With the advent of next-generation sequencing, the list of diverse non-coding RNA species with
functional capacity expressed in eukaryotic cells has grown very rapidly and some computational
algorithms emerged to predict circRNAs, which were most commonly found at back-splicing
junctions (Veneziano et al., 2016; Gao and Zhao, 2018).
Abbreviations: AD, Alzheimer’s disease; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukaemia; APL, acute
promyelocytic leukemia; BMSCs, bone marrow stem cells; circRNA, Circular RNA; CML, chronic myeloid leukemia; CSCs,
cancer stem cells; DMD, Duchenne muscular dystrophy; EMT, epithelial mesenchymal transition; FLT3, FMS-like tyrosine
kinase-3; GBM, glioblastoma multiforme; GCs, granulosa cells; HCC, hepatocellular carcinoma; HSCs, hematopoietic stem
cells; MIBC, muscle invasive bladder cancer; miRNA, micro RNA; NGS, Next Generation Sequencing; OBs, osteoblasts; OCs,
osteoclasts; OS, osteosarcoma; PD, Parkinson’s disease; PML/RARα, promyelocytic leukemia-retinoic acid receptor α; RA,
Retinoic Acid; RBP, RNA-binding protein; RNA-seq, RNA sequencing; SSC, spermatogonial stem cells; SZ, Schizophrenia;
VIM, vimentin.
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Circular RNA (circRNA) is a type of single-stranded RNA
usually formed by alternative splicing of pre-mRNA where
the 5′ upstream splice acceptor is joined to 3′ downstream
splice donor in a process named “backsplicing” (Figure 1).
This event forms covalently closed continuous loops without
polyadenylated tails and, as result, circRNAs are insensitive
to the majority of exoribonucleases (Kristensen et al., 2019).
CircRNAs are classified into three categories: exonic circRNAs
(ecircRNAs; with one or more exons) that represent 85% of all
circRNAs, exonic-intronic circRNA (EicirRNA) and circularized
intronic RNA (ciRNA) (Kristensen et al., 2019; Figure 1).
A competitive relationship may exist between the linear RNA
splicing and the back-splicing events. The two introns flanking
the circularized exons, which have been found to be enriched
in Alu repeats, usually increase the efficiency of circularization
(Zhang et al., 2014).
Initially, circRNAs were occasionally discovered by RT-PCR
amplification and sequencing (Nigro et al., 1991; Cocquerelle
et al., 1992). Only 20 years later, to find genomic rearrangements
in cancers, the expression of circRNAs was discovered through
RNA-seq in human pediatric acute lymphoblastic leukemia
(Salzman et al., 2012). The authors showed that this phenomenon
could be extended to leukocytes from healthy adults as well as to
several other cancer and non-cancer cell lines and to mouse brain
(Salzman et al., 2012).
The most important features of circRNAs can be summarized
as follows: (a) circRNAs are abundant forms of non-coding RNAs
that are expressed from thousands of human genes, sometimes
even at higher level than their cognate linear isoforms (Salzman
et al., 2012; Zhang et al., 2014; Kristensen et al., 2019); (b)
circRNAs exhibit cell type-specific expression (Chen, 2016);
and (c) circRNAs present a high rate of conservation between
mouse and human and are quite stable molecules, with half-lives
exceeding 48 h (Jeck et al., 2013).
Circular RNAs could have multiple functions within the cell
acting for example as miRNA sponges, by competing for miRNA
binding sites and thus decreasing the miRNA activity on the
target mRNA, or acting as protein sponges; moreover, circRNA
can interact with RNA-binding proteins (RBPs), act as platform
for enzimatic reactions or act as a protein platform (Figure 2);
finally, circRNAs may regulate the transcription and may interact
with ribosomes thus affecting protein translation (Kristensen
et al., 2019; Figure 2).
CircRNAs IN EMBRYOGENESIS
The embryo development begins when the genetic transcription
of zygote is activated. Different from the intensely studied
mRNAs, circRNAs are still in the opening of this research field. By
means of deep sequencing and bioinformatics technologies, the
set of circRNA expressed in human pre-implantation embryos
have been reported (Fan et al., 2015; Dang et al., 2016).
Embryonic stem cells derived from the pluripotent inner cell
mass of the blastocyst are clonogenic and have the ability for
unlimited self- renewal and pluripotency, leading to all cell types
in the human body tissues. That ncRNAs play an important
role in the maintenance of pluripotency has been recently
established (Fu et al., 2018). Specifically, it has been demonstrated
that two circRNAs, namely circBIRC6 and circCORO1C, are
functionally connected with the maintenance of pluripotency
in human embryonic stem cells and, in particular, circBIRC6
acts as a sponge for miR-34a and miR-145, relieving the
suppression of NANOG, OCT4, and SOX2 espression (Yu et al.,
2017). In an widely used vertebrate model, aimed at exploring
circRNAs with potential functions during early vertebrate
development, Liu et al. performed high-throughput sequencing,
and applied the circRNA Identifier algorithm, throughout the
duration of zebrafish embryo development (Liu et al., 2019);
this study provided important information on the dynamic
regulation of circRNAs implicated in the control of zebrafish
differentiation and described novel specific circRNAs responsible
for embryo development.
The possible role and impact of circRNAs in human
development have been also recently reported with specific
regard to cardiogenesis and neurogenesis (Lee et al., 2019). Of
note, circRNAs were shown to be more abundant in the brain
than in other tested organs in the adult mouse (You et al., 2015),
pig (Veno et al., 2015), and human (Chen B. J. et al., 2019).
The expression and roles of circRNAs in brain development and
aging as well the implications in CNS diseases have been recently
reviewed (Mehta et al., 2020).
CircRNAs IN REPRODUCTIVE SYSTEM
AND GERM CELL DEVELOPMENT
During spermatogenesis and oogenesis, a tightly controlled
expression of stage-specific genes is crucial for the
normal development of gametes. Recently, circRNAs have
emerged as a novel class of ncRNAs that regulate gene
expression also in gametogenesis, but their role has not
been completely clarified yet.
A study focused on the expression levels of circRNAs in brain,
liver, heart, lung and testis, indicated that testis produces a huge
amount of circRNAs, only second to that in brain (You et al.,
2015), suggesting that circRNAs may have an important role in
the testis function.
Notably, about 30 years ago the first circRNA was discovered
in mouse as a transcript originating from the testis-determining
gene Sry (Capel et al., 1993). In male, spermatogonial stem cells
(SSCs) undergo self-renewal to ensure at the same time the
maintenance of the stem cells pool and the differentiation to
spermatocytes and spermatids. SSCs can also dedifferentiate into
embryonic stem (ES)-like cells to acquire pluripotency in vitro
(Conrad et al., 2008) and they are able to be reprogrammed
to transdifferentiate to cell lineages of other tissues and for
this reason SSCs have relevant applications in treating male
infertility (Chen et al., 2017). Distinct circRNA expression
profiles in different types of male germ cells indicate an important
role exerted by circRNAs in the control of self-renewal and
differentiation processes of SSCs (Zhou et al., 2019). By using
highthroughput sequencing, circRNAs expression profiles have
been identified in mouse male and female germline stem cells: a
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FIGURE 1 | circRNA generation by “backsplicing” mechanism. Diverse circular RNAs (circRNAs) can be formed from a single gene. The non-canonical splicing
process named “backsplicing” is the responsible of the circRNA formation. A downstream splice donor is joined to an upstream splice acceptor generating diverse
isoforms. Such circRNAs can consist of one or more exons and can even contain unspliced intronic sequences. Circularized intron RNAs are not produced by
backsplicing, rather by an inefficient debranching. Colored bars, exons; black lines, introns.
FIGURE 2 | Schematic representation of circRNA functions. (A) CircRNAs may act as miRNA sponges by competing for miRNA binding sites, decreasing the
miRNA activity on the mRNA targets. (B) CircRNAs may act as protein sponges, by binding RNA-binding proteins (RBPs) or acting as platform for enzymatic
reactions or acting as a protein platform. (C) CircRNAs may regulate the transcription. (D) CircRNAs may interact with ribosomes and affect protein translation.
total of 18822 circRNAs were described in the germline stem
cells and 921 circRNAs were differentially expressed between the
male and female germline stem cells, suggesting that circRNAs
could confer sex-specific properties needed for differentiation
into gametes between male and female stem cells in mouse (Li
X. et al., 2017; Li et al., 2019).
Moreover, testis-derived circRNAs have been detected in
human seminal plasma because they are resistant to exonuclease
activity due to their circular form which confer them a great
potential as liquid biopsy tools for various human diseases
(Dong et al., 2016; Cai et al., 2018). Interestingly, in a recent
study the expression of eight candidate circRNAs generated
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from six linear transcripts (CNR1, LEPR, MTHFR, NAPEPLD,
NPC2, and SIRT1) has been profiled in five RNA samples
from human and murine spermatozoa. Among them, authors
focused on circNAPEPLDiso1, investigating its ability to bind
miRNAs; they showed that circNAPEPLDiso1, expressed in
mouse and human spermatozoa, specifically interacts with five
miRNAs (miR-146a-5p, miR-203a-3p, miR-302c-3p, miR-766-
3p, and miR-1260a) involved in the control of cell cycle and, some
of them, expressed by the oocyte. This finding suggests a role
of circNAPEPLDiso1 as a paternal-derived sponge for miRNAs
inside the fertilized oocytes to regulate the first stages of embryo
development by increasing levels of miRNA targets (Ragusa et al.,
2019; Figure 3A).
An exhaustive review has recently described the potential roles
of circRNAs in reproduction, particularly by analyzing circRNAs
expression pattern in ovary (Quan and Li, 2018). Granulosa cells
(GCs), the somatic cells surrounding oocyte, play an important
role during oogenesis and early stages of embryo development
(Moreno et al., 2015) and the study of circRNAs expressed in the
GCs of subjects undergoing in vitro fertilization at a young age
(less than 30 years) and at an older age (more than 38 years)
showed that in older women, the expression of 46 circRNAs
was up-regulated, whereas, 11 circRNAs were down-regulated. In
particular, a negative correlation between the elevated expression
of circRNA_103827 and circRNA_104816 in GCs and the top
quality embryo number has been shown, suggesting that both
circRNAs were closely related to decreasing ovarian reserve
and adverse reproductive outcomes (Figure 3A). Therefore,
circRNAs pattern of GCs may be used as potential biomarker to
predict oocyte developmental capability and consequent assisted
reproduction outcome (Cheng et al., 2017).
CircRNAs IN CELL DIFFERENTIATION
Circular RNAs are expressed in several different organs following
a spatial- and temporal-specific course, which suggests their
potential biofunctions (Chen and Schuman, 2016; Zhao W.
et al., 2019). To date, there is a growing number of studies
reporting that circRNAs could be involved in the development of
mammalian tissues as in neural development (van Rossum et al.,
2016; Constantin, 2018), in osteogenic differentiation (Gu et al.,
2017; Huang et al., 2019), in skeletal muscle development (Chen
et al., 2020) or in hematopoiesis (Bonizzato et al., 2016).
Neuronal CircRNAs
Several recent reports have shown that circRNAs are more
enriched in neuronal tissues respect to other tissues (Chen
and Schuman, 2016; Figure 3B). The reasons may be: (i)
the brain has a consistent number of expressed circRNA host
genes such as neuronal genes which regulate neurogenesis,
neurodevelopment, and neuronal differentiation (Rybak-Wolf
et al., 2015); (ii) neuronal genes contain very long introns
(>10 kb), and circularized exons are more frequently flanked
by long introns with inverted repeated sequences, thereby
facilitating formation of circRNAs (Jeck et al., 2013); (iii) as
circRNAs haven’t 5′ and 3′ ends, they are more stable than
linear coding or non-coding RNAs, leading to a relatively longer
half-life (Piwecka et al., 2017).
The first study of circRNAs in neuronal development
documented their significant enrichment in brain and most
of them were derived from host genes that code for synaptic
proteins. The authors profiled the mouse circRNA population
in the hippocampus over several stages: embryonic (E18),
early postnatal (P1), postnatal at the beginning of synapse
formation (P10) and late postnatal hippocampus following
the establishment of mature neural circuits (P30) (You et al.,
2015). They observed that circRNA expression pattern associated
with the onset of synaptogenesis at P10. Interestingly, the
circRNAs that were induced during hippocampal development
were transcribed from the gene loci coding for proteins enriched
with synapse-related functions (You et al., 2015). Interestingly,
using high resolution in situ hybridization, for the first time, this
study visualized circRNA punctae in the dendrites of neurons.
These data show that circRNA expression levels are regulated
by neural plasticity, suggesting their importance in regulating
synaptic transmission and/or local translation.
As circRNAs are found to be preferentially expressed
along neural genes and in neural tissues, several research
groups focused their efforts on the study of the circRNAs
involvement as new biomarkers for aging-correlated multiple
sclerosis characterized by neurodegeneration, the mental illness
schizophrenia and for the neurodegenerative pathologies as
Alzheimer’s disease (AD), Parkinson’s disease (PD) (Ghosal
et al., 2013; Lukiw, 2013). AD is the most common cause of
dementia worldwide characterized by progressive dysmnesia,
cognitive impairment, and psychiatric symptoms. Although
the mechanisms of onset and progression of AD remain
unknown, the primary clinicopathological characteristics of AD
are aggregates of amyloid precursor protein-derived amyloid-β
(Aβ) peptides and intraneuronal neurofibrillary tangles in the
brain. Targeted molecular therapies for the treatment of AD have
recently entered in medical practice (Chang et al., 2018).
Dysregulation of miR7-ciRS-7 interaction has been reported
in the hippocampus of AD patients, where the expression of
ciRS-7 is low and, therefore, the level of miR-7 is increased, with
consequent down-regulation of miR-7 target mRNAs (Lukiw,
2013; Floris et al., 2017; Figure 3B). The dysregulation of
the interaction between ciRS-7 and miR-7 has been reported
to be crucial for other neuronal disorders, including PD,
where ciRS-7 has a sponge activity on miR-7 expression (Lu
and Xu, 2016; Floris et al., 2017; Figure 3B). In fact, miR-
7 is highly expressed in cortical neuronal progenitors and its
depletion causes microcephaly-like brain defects (Piwecka et al.,
2017; Table 1).
Parkinson’s disease is characterized by loss of dopaminergic
neurons in the substantia nigra, which leads to a series of motor
function disorders including rest tremor, muscular rigidity,
and bradykinesia. The overexpression and aggregation of α-
synuclein (SNCA), which is present in Lewy bodies, is a
distinctive diagnostic marker in PD (Rodriguez et al., 2015).
It has been shown that miR-7 overexpression induced more
efficient repression of SNCA in the empty HeLa cell line that
did not express ciRS-7, suggesting that ciRS-7 may play a role in
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FIGURE 3 | Selected functional effects of circRNAs in development and cancer. (A) Potential roles of circRNAs in reproduction: circRNAs expressed in granulosa
cells (GCc) and in spermatozoa and involved in the first stages of embryo development into the fertilized oocytes are shown. (B) Roles of circRNAs in brain disease:
in the Hippocampus, dysregulation of ciRS-7 expression is associated with Alzheimer’s disease and, generally, with neuronal-associated diseases. CiRS-7/CDR1as
deregulated expression is also involved in brain tumorigenesis. (C) The PTBP1-circMYBL2 complex is highly expressed in AML patients with FLT3-ITD mutations
where the translation of FLT3 mutated kinase is specifically induced fostering tumor progression.
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TABLE 1 | CircRNAs expressed in neuronal tissue and neuronal diseases.
circRNA Function References
ciRS-7 Hansen et al., 2013
Floris et al., 2017
Sponge activity on miR-7 Lu and Xu, 2016
Sang et al., 2018
hsa_circRNA_104597 Valuable marker for schizophrenia Yao et al., 2019
CDR1as Hansen et al., 2013
Kalinowski et al.,
2014
Uhr et al., 2018
Sponge activity on miR-7 Tanaka et al., 2019
Zhong et al., 2019
circFBXW7 Tumor suppressor Yang et al., 2018
circSHPRH Tumor suppressor Zhang et al., 2018
modulating SNCA through a miR-7-dependent pathway (Hansen
et al., 2013). These results also suggested a possible sponge effect
between ciRS-7 and miR-7 in vitro. Other studies reported that
circSNCA can sponge miR-7 thereby up-regulating expression
of SNCA mRNA, resulting in reduced autophagy and increased
apoptosis in SH-SY5Y cells (Sang et al., 2018).
Schizophrenia (SZ) is a serious neuropsychiatric disorder
with high recurrence and disability rates (van Os and Kapur,
2009). The pathogenesis of SZ is not yet fully understood
and the most accredited causes seem to be environmental and
genetic factors, although the lack of reliable biomarkers hinders
early diagnosis and effective treatment of SZ patients (van Os
and Kapur, 2009). Very recently, to assess whether expression
of circRNAs in peripheral blood mononuclear cells (PBMCs)
may be useful as low invasive biomarkers for diagnosis and/or
therapeutic response in SZ patients, a research group analyzed
circRNA expression profiles in PBMCs from SZ individuals
and healthy controls (Yao et al., 2019). The expression of
hsa_circRNA_104597 was assessed to be at low level in patients
affected by schizophrenia (Yao et al., 2019; Table 1). ROC
curve analysis showed that hsa_circRNA_104597 alone had
a sensitivity of 84.31% and specificity of 86.41% respect to
hormones (e.g., cortisol, insulin, leptin, prolactin, and growth
hormone), miRNAs, lncRNA,indicating it as diagnostically
valuable marker (Yao et al., 2019). In addition, they found
that hsa_circRNA_104597 expression level increased after the
treatment for 8 weeks with antipsychotic medications confirming
it as potential therapeutic biomarker for SZ (Yao et al., 2019).
CircRNAs in Osteogenic Differentiation
Bone remodeling is a dynamic process based on the balanced
activities of the bone-forming osteoblasts (OBs), differentiating
from bone marrow-derived mesenchymal stem cells (MSCs),
and the bone-resorbing osteoclasts (OCs), multinucleated cells
deriving from the monocyte/macrophage lineage (Berendsen
and Olsen, 2015). Mature OBs produce and secrete proteins,
such as alkaline phosphatase and type I collagen, which are
necessary for the formation of the bone extracellular matrix,
which then undergoes the process of mineralization. While
most of the OBs die by apoptosis, some reach quiescence as
bone lining cells on bone surfaces or become embedded in the
bone matrix as osteocytes (Berendsen and Olsen, 2015). OCs
control calcium and phosphate homeostasis, and play the role of
mechano-sensors to respond to mechanical effort of the skeleton
(Berendsen and Olsen, 2015). The cellular crosstalk of OBs and
OCs is important to ensure bone integrity, repair, and calcium
homeostasis, and imbalance between OB and OC activities can
lead to bone diseases, such as osteoporosis and cancer-associated
bone destruction (Berendsen and Olsen, 2015).
Several microRNAs and long non-coding RNAs have been
reported as differentially expressed during osteogenesis (Ell and
Kang, 2014; Huynh et al., 2017; Xie et al., 2017; Puppo et al.,
2019). Their involvement in bone cancer and metastasis is well
addressed (Puppo et al., 2019). Nevertheless, little is known about
the regulation of the expression and the role of circRNAs in bone
development and in bone pathologies.
Circular RNAs are emerging as important molecules that
may regulate bone homeostasis. Using gene expression analysis,
several circRNAs were found to be differentially expressed
in MSCs undergoing OB differentiation, respect to their
undifferentiated counterparts (Zhang et al., 2019). Some
circRNAs were linked to miRNAs with osteogenic roles,
indicating that these circRNAs potentially function in osteogenic
differentiation of BMSCs (bone marrow stem cells) (Zhang et al.,
2019). The authors identified a crosstalk between miR-199b-5p
and circIGSF11 (Table 2). Silencing of circIGSF11 promoted
osteoblast differentiation and increased the expression of miR-
199b-5p (Zhang et al., 2019).
It has been reported that BMP2 promoted the proliferation
of osteoblasts in vitro (Qian et al., 2017). RNA-seq analysis of
BMP2-treated MC3T3-E1 cells has been performed to analyze
differential expression of circRNAs during different osteoblast
differentiation stages (Qian et al., 2017). 158 circRNAs were
differentially expressed and, specifically, the expression of
circRNA.5846, circRNA.19142 and circRNA.10042 was increased
in the BMP2 treated group (Table 2). Circ.19142 and circ.5846
were found to be not only strongly associated with the positive
regulation of developmental processes but also related to the
fibroblast growth factor, epidermal growth factor, platelet-derived
growth factor and Wnt signaling pathways, which are involved in
cell growth and differentiation (Qian et al., 2017).
TABLE 2 | CircRNAs in osteogenic differentiation and pathologies.
circRNA Function References
circIGSF11 Interaction with miR-199b-5p Zhang M. et al., 2019
circ19142 Osteoblastic differentiation Qian et al., 2017
circ5846
hsa_circ_0006393 Sponge activity on miR-145-5p Wang Y. et al., 2019
hsa-circ-0016347 Onco-circRNA in osteosarcoma Jin et al., 2017
circHIPK3 Xiao-Long et al., 2018
circ_001569
circ-Cdr1as Tumor suppressor
circ-Foxo3
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Recently, Wang X.B. et al. (2019) found that the
overexpression of hsa_circ_0006393 increased the expression
level of genes associated with osteogenesis (Table 2).
Hsa_circ_0006393 is expressed mainly in the cytoplasm
and nucleus of BMSCs. miR-145-5p was shown to
be sponged by hsa_circ_0006393, thus increasing the
expression levels of osteogenic genes during bone remodeling
(Wang X.B. et al. (2019)).
Unfortunately, no functional analysis was carried
out. Additional investigations and functional studies are
required to address the biological role of circRNAs in bone
differentiation and remodeling.
CircRNAs in Skeletal Muscle
Development
Recent studies reported that circRNAs are well expressed in
skeletal muscle tissue, and their expression levels are regulated
during muscle development and aging (Cai et al., 2019; Zhang
M. et al., 2019). Skeletal muscle is the largest tissue in the body,
playing an important role in locomotion and metabolism (Millay
et al., 2013). Skeletal muscle has mature cells that are syncytial
and can contain hundreds of nuclei; therefore, correct muscle
growth and homeostasis are determinant for human mobility.
Conversely, muscular diseases, such as muscular dystrophy,
sarcopenia, atrophy, and cachexia, severely affect the everyday
life of humans (Millay et al., 2013). Development and growth
of muscle mainly rely on the proliferation and differentiation of
myogenic stem cells. Most of the myogenic stem cells are derived
from the mesodermal cell lineages (Kuang et al., 2007) and Pax3
and Pax7 paired box genes are the principal biomarkers for the
myogenic stem cell (Buckingham and Relaix, 2007).
Regarding the expression of circRNAs in the muscle and in its
development, many studies have been performed on mouse and
chicken embryos (Chen et al., 2018; Shen et al., 2019).
Duchenne muscular dystrophy (DMD), which is characterized
by a progressive decrease of muscle function, is caused by frame-
shifting deletions or nonsense mutations in the DMD gene
(Koenig et al., 1989), being this last among the first genes where
circRNAs were identified as RNA circles consisting of exons that
were skipped by alternative splicing (Surono et al., 1999). In
contrast to the previous idea that circRNAs might be derived
from aberrant splicing events (Sharp, 1994), the formation of
circRNAs from the DMD gene is not necessarily created by
the exon skipping, mainly because no strong correlation has
found between the identified spliced transcripts and the circRNAs
expected to be produced (Surono et al., 1999).
A recent work showed that most of the circRNAs expressed
in myoblast during the growth stage regulated the cell cycle,
while the circRNAs expressed in the differentiation stage are
related with development activity (Zhang et al., 2018). For
examples, circZNF609 showed higher expression in myotubes
than in myoblasts and its downregulation reduced myoblast
proliferation (Legnini et al., 2017; Table 3). In the mouse model a
proposed mechanism implies that circZNF609 inhibits myoblasts
differentiation by sponging miR-194-5p and upregulating
BCLAF1 (Wang Y. et al., 2019).
CircLMO7, derived from LMO7 gene, was highly expressed
in skeletal muscle tissue. High levels of circLMO7 significantly
decreased the expression of MyoD and myogenin (MyoG),
suggesting that circLMO7 inhibited myoblast differentiation
(Table 3). On the other side, circLMO7 overexpression increased
myoblasts proliferation (Wei et al., 2016). From a mechanistic
point of view, circLMO7 interacted with miR-378a-3p that
targeted HDAC4 expression (Wei et al., 2016). CircLMO7 may
serve as a decoy for miR-378a-3p, resulting in higher expression
of HDAC4 thus decreasing the transcription of MEF2A and
repressing myoblast differentiation (Miska et al., 1999).
Conversely, circSNX29 expression is correlated with
myoblasts differentiation. It was reported that the expression
level of circSNX29 was much higher in embryonic skeletal
muscle than adult skeletal muscle and it was principally enriched
in the cytoplasm (Peng et al., 2019; Table 3). CircSNX29 acts as a
miR-744 sponge and increases Wnt5a and CaMKIId expression
resulting in the activation of non-canonical Wnt pathways and
myoblasts differentiation. Other groups have documented a
similar “sponge” mechanism for other circRNAs, by sequestering
miRNAs that regulate the expression of genes positively or
negatively implicated in myoblasts differentiation (Li H. et al.,
2018; Ouyang et al., 2018).
Many evidences of circRNAs dysregulation in muscle diseases
are emerging. As previously mentioned, circRNAs produced
by transcripts spliced from the DMD gene were among the
first to be identified in skeletal muscles, mostly generated at
the 5′ end of the transcript (Surono et al., 1999). Recently, a
region spanning exon 45 to exon 55 of the DMD gene that
represents a deletion hotspot in 63% of DMD patients was
characterized (Suzuki et al., 2016). The authors reported that
multiple exon skipping, targeting exon 45-55, was related with the
increase of the symptoms in the patients identifying the favorite
splice-sites involved in both circRNA formation and in multiple
exon skipping of exon 45-55. The data confirm a circRNA-
generation model in which the interaction between upstream and
downstream introns triggers multiple exons skipping and creates
circRNAs (Suzuki et al., 2016).
CircRNAs in Hematopoiesis
Next Generation Sequencing (NGS) recently showed a
conspicuous circRNA expression in human hematopoietic
progenitors, and in differentiated lymphoid and myeloid cells
(Nicolet et al., 2018). In the hematopoietic compartment,
circRNAs are significantly enriched and secreted in vesicles
named exosomes derived from platelets, where circRNAs
TABLE 3 | CircRNAs in skeletal muscle development and diseases.
circRNA Function References
circZNF609 Sponge activity on miR-194-5p Legnini et al., 2017; Wang Y.
et al., 2019
circLMO7 Sponge activity on miR-378a-3p Miska et al., 1999;
Wei et al., 2016
circSNX29 Sponge activity on miR-744 Peng et al., 2019
circLPAR1 Biomarker for the prognosis of MIBC Lin et al., 2019
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resulted to be more abundant and widely expressed compared
with other cell types (Preußer et al., 2018).
In the hematopoietic system, circRNA expression is cell-type
specific, and it increases upon cell maturation. CircRNA splicing
variants can also be cell-type specific (Nicolet et al., 2018). In the
bone marrow, the hematopoietic stem cells (HSCs) differentiate
into various progenitor cells, which in turn generate many types
of myeloid and lymphoid cells requiring a tight regulation of
gene expression of transcription factors and non-coding RNAs
(Goode et al., 2016).
In a cutting-edge article dating back 20 years, Caldas et al.
(1998) documented in the hematopoietic tissue the expression
of circRNA isoforms of key genes such as MLL although the
work was not very successful at the time, probably because the
expression of circular isoforms was lower than mRNAs encoding
the key transcriptional regulators.
CircRNAs IN CANCER: NOVEL
DIAGNOSTIC AND THERAPEUTIC
BIOMARKERS
One of the peculiar characteristics of circRNAs is that they are
more resistant to the enzymatic activity of RNase R than linear
mRNA, bypassing common RNA turnover steps (Kristensen
et al., 2019). This feature has been exploited by liquid biopsies
in the context of clinical trials conducted on various pathologies
including cancer. Thanks to the stability of their structure in
the longtime, it has been easy to trace the circRNAs in human
tissues and fluids as serum and urine (Zhang et al., 2018). Their
presence or absence in the fluids is emerging as an attractive
diagnostic and prognostic tool and for this reason, in the field
of translational medicine, they are becoming potent non-invasive
biomarkers (Meng et al., 2017; Zhang et al., 2018).
The list of circRNAs involved in carcinogenesis continues
to grow, however, the functional relevance of the vast majority
is yet to be discovered. Some circRNAs can act as oncogenes
and sustain proliferative signaling in cancer progression, while
others may behave as tumor suppressors (Kristensen et al., 2018).
Therefore, the cancer-specific expression status and functional
mode of circRNAs may be used in cancer diagnosis and precise
treatment in the future.
CircRNAs in Hematological Disease
Hematological cancers are characterized by the aberrant growth
of oligoclones of hematopoietic cells, which are able to invade
the bone marrow and the blood, leading to severe anemia
and immunodeficiency (Handschuh, 2019). Recently, using
NGS technology, Salzman et al. (2012) addressed new cancer-
specific fusion transcripts in hyperdiploid B-lineage acute
lymphoblastic leukemia (ALL). They sequenced several RNA
transcripts with numerous combinations in which the exons
could merge (“scrambled exons”) and identified circularized
RNAs. In five samples of hyperdiploid B-cell precursor-acute
lymphoblastic leukemia they observed hundreds of circRNA
transcripts with >700 circular isoforms where more than 10%
of all transcripts derived by a comparable number of genes
(Salzman et al., 2012). This study showed that many genes
could produce scrambled exons (ESYT2, FBXW4, CAMSAP1,
KIAA0368, CLNS1A, FAM120A, MAP3K1, ZKSCAN1, MANBA,
ZBTB46, NUP54, RARS, and MGA) but they were expressed
both in normal and blood cancer cells, not providing a more
specific and useful interpretation of circRNA relevance for
hematopoietic cell functions and pathology (Salzman et al., 2012).
In a more recent study, RNA-seq analysis from whole-blood
samples reported a very high number of expressed circRNAs,
comparable to the brain (Memczak et al., 2015). Also in this
case the functional aspect of circRNAs expression was not
investigated but it was observed that hundreds of circRNAs
were much higher expressed than corresponding linear mRNAs
(Memczak et al., 2015).
If little is documented about the function of circRNAs
in the development of hematopoietic tissue, much has been
documented on their role in leukemias (Mei et al., 2019).
Acute myeloid leukaemia (AML) represents the clonal expansion
of hematopoietic precursors blocked at different stages of
differentiation. The pathogenesis of AMLs is correlated to
the presence of genetic alterations and the transcription
factors regulating myelopoiesis are consistently involved in
chromosomal translocation (Tenen et al., 1997). In AML
the molecular event related to the transfation ability of
chromosomal translocation-generated AML fusion proteins
(such as PML/RARa, PLZF/RARa, AML1-ETO, MLL/AF9)
is strictly dependent on their capacity to induce abnormal
epigenetic modification on genes relevant to the transformation
process (Grignani et al., 1998; Di Croce et al., 2002; Fazi et al.,
2007). Of note, recently, fusion-circRNAs (f-circRNAs) derived
from transcribed exons of chimeric proteins as MLL/AF9 and
PML-RARA, generated by leukemia-associated chromosomal
translocation, were discovered and demonstrated to be oncogenic
by in vitro and in vivo experiments (Guarnerio et al., 2016;
Table 4). Guarnerio et al. (2016) showed that f-circPR and f-
circM9 expression in leukemic cells increases cell proliferation
and clonogenicity and that f-circRNA silencing reverted the
phenotype, demonstrating that these f-circRNAs are biologically
active and play pro-proliferative and pro-oncogenic activities.
Recently it was reported that circ-VIM expression level in de
novo AML patients [non-Acute Promyelocytic Leukemia (APL)
patients with normal karyotype] was significantly upregulated
compared with that in healthy controls (Yi et al., 2019; Table 4).
TABLE 4 | CircRNAs in hematopoiesis and cancer.
circRNA Function References
f-circPR f-circM9 Pro-oncogenic activities in leukemia Guarnerio et al., 2016
circ-VIM Up-regulated in AML Yi et al., 2019
circ-HIPK2 Biomarker in APL Li et al., 2018
circMYBL2 Required for FLT3-dependent
leukemia progression
Sun et al., 2019
circ-PVT1 Pro-oncogenic activities in AML Hu et al., 2018
hsa_circ_0004277 Biomarker in AML Li et al., 2018
circ-BA9.3 Pro-oncogenic activities in CML Kaleem et al., 2015;
Pan et al., 2018
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Vimentin (VIM) is a component of type III intermediate
filament protein, involved in the regulation of lymphocyte
adhesion and transcellular migration, and is associated with
poor clinical outcome in older patients with AML (Wu S.
et al., 2018). Collectively, these results make circ-VIM as a
promising diagnostic biomarker and treatment target in AML
(Yi et al., 2019).
Mutations within the FMS-like tyrosine kinase-3 (FLT3)
gene, resulting in the internal tandem duplication (ITD;
FLT3-ITD) or in the tyrosine kinase domain mutation
(TKD; FLT3-TKD), occur in approximately 30% of AML
patients. Recently, it has been shown that circMYBL2, a
circRNA generated from the circularization of the cell-cycle
checkpoint gene MYBL2, is crucial for FLT3-dependent leukemia
progression. Mechanistically circMYBL2, by interacting with
the polypyrimidine tract-binding protein 1 (PTBP1) to FLT3
messenger RNA significantly increases the protein level of
mutant FLT3 kinase contributing to the AML progression. The
depletion of this circRNA significantly impairs tumorigenicity
of FLT3-ITD AML cells, highlighting this circRNA as putative
relevant therapeutic target in this AML subtype (Sun et al.,
2019; Figure 3C).
Of note, APL is a subtype of AML, characterized by
the presence of the promyelocytic leukemia-retinoic acid
receptor α (PML/RARα) fusion protein, which induces an
oncogenic transcriptional silencing of the Retinoic Acid (RA)
signaling pathway and causes the block of differentiation at
the promyelocytic stage and neoplastic transformation of APL
blasts (Grignani et al., 1998; Di Croce et al., 2002). Of note,
the treatment of APL blasts with pharmacological doses of RA
can overcome this repression and induce terminal differentiation
in vitro and in vivo (Fazi et al., 2005). Gene expression
analysis by RNA-seq showed 4,313 APL-expressed circRNAs in
NB4 cells (Li et al., 2018). Furthermore, 508 circRNAs were
expressed during all-trans retinoic acid treatment. The expression
of circ-HIPK2 was lower in AML cells compared with APL
cells, and overexpression of circ-HIPK2 increased differentiation
in NB4 cells (APL cells with PML-RARA) (Li et al., 2018).
Furthermore circ-HIPK2 had lower expression in APL samples
of patients respect to that in healthy control samples and other
subtypes of AML cases. The expression level of circ-HIPK2
significantly increased when APL patients achieved complete
remission. This may suggest that circ-HIPK2 could act as a
biomarker in APL cells.
Other circRNAs have been identified in hematopoietic
malignancies as for example: circ-PVT1 in AML and in head
and neck squamous cell carcinoma, where its expression is
significantly associated with mutant p53 (Verduci et al., 2017;
Hu et al., 2018; Table 4); hsa_circ_0004277, significantly lower
in the AML than in healthy controls and patients who entered
complete remission after treatment (Li W. et al., 2017; Table 4);
circ-BA9.3 in chronic myeloid leukemia (CML), which is a stem
cell disorder of uncontrolled myeloid proliferation characterized
by the reciprocal translocation t(9;22) (q34; q11.2) resulting in the
BCR-ABL1 fusion (Kaleem et al., 2015; Pan et al., 2018; Table 4).
Different cirRNA expression profiles correlate with different
types of leukemia and clinical features, including tumor stage
and recurrence, supported by recent RNA-seq studies. From all
these studies it is clear that circRNA dysregulation signatures in
cancers (in tissue- and development stage-specific manner), their
tumor suppressive/oncogenic roles and stability and abundance
in body fluids make them attractive non-invasive biomarkers in
liquid biopsies.
CircRNAs in Brain Tumors
Many articles about the involvement of circRNAs in brain
tumors are emerging due to their versatility and hypothetical
use for liquid biopsy-based diagnosis and prognosis. Glioma
is a common type of central nervous system tumor where
diffuse glioma (glioma cells exhibiting extensive invasive growth
into the surrounding central nervous system) is the most
frequent tumor especially in adults (Wesseling and Capper,
2018). Song et al. (2016) conducted a study that included
seven oligodendrogliomas, 20 glioblastomas and 19 normal brain
specimens to explore the expression level of circRNAs using
high-throughput sequencing. To analyze the great number of
raw data, the authors developed a sofisticated computational
pipeline named UROBORUS. They found that the total number
of detected circRNAs in GBM was significantly lower than that
in normal brain tissue showing that eight highly expressed
GBM-specific circRNAs might be good GBM-specific biomarker
candidates (Song et al., 2016).
Among the first circRNAs identified and studied in brain
cancer there is the one originating from the antisense transcript of
the cerebellar degeneration-related protein 1 gene (CDR1as, also
known as ciRS-7, previously described) that many reports have
considered to have miRNA sponge activity (Hansen et al., 2013;
Memczak et al., 2013; Kalinowski et al., 2014; Barbagallo et al.,
2016; Zou et al., 2019; Table 1 and Figure 3B).
Mature ciRS-7 as is principally expressed in the cytoplasm, it
has 74 miR-7 binding sites that can specifically bind to miR-7
molecules. As a result, the miR-7 target mRNAs are released from
binding to miR-7 (Hansen et al., 2013; Kalinowski et al., 2014).
The same seizure mechanism of ciRS-7 as toward miR-7 has been
reported in development of nasopharyngeal carcinoma (Zhong
et al., 2019), in colon cancer (Tanaka et al., 2019), in breast cancer
(Uhr et al., 2018) and others.
Interestingly, Pamudurti et al. published that some circRNAs
are associated with ribosomes suggesting a possible translation
into proteins (Pamudurti et al., 2017). About this, it has
been reported that circFBXW7 has coding potential and
that translated peptide could be bound by an antibody
targeted to related sequences holding potential prognostic
implications in brain cancer (Yang et al., 2018). CircFBXW7
expression can significantly inhibit cell progression, migration,
and tumor formation in vivo acting as tumor suppressor
(Yang et al., 2018; Table 1). In this study FBXW7-185aa
reduced the half-life of c-Myc by antagonizing USP28-
induced c-Myc stabilization. An in situ GBM mouse model
revealed the tumor suppressing effect of FBXW7-185aa but
not of circ-FBXW7 circRNA with an IRES mutation. Also
circSHPRH has coding abilities and leads to the formation
of a peptide (Zhang M. et al., 2018). SHPRH-146aa is
downregulated in GBM compared with para-cancerous tissues
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and overexpression of SHPRH-146aa significantly inhibited
glioma growth in xenograft mouse models (Zhang M. et al.,
2018; Table 1).
Altogether these data highlighted that circRNAs in brain
tumors could be excellent biomarkers for their diagnosis,
prognosis and classification. According to this idea, some
groups reported that the knockdown of oncogenic circRNAs
might be a reasonable approach for the treatment of glioma
in the future. On the contrary, circRNAs that play tumor
suppressor activity might be used in overexpression therapies.
Novel approaches to express proteins acting as potent tumor
suppressors in brain tumor models by engineering a circRNA
vector have been also recently published, suggesting a circRNA-
based treatment of glioma in the near future (Meganck et al.,
2018; Wesselhoeft et al., 2018).
CircRNAs in Osteosarcoma
Osteosarcoma (OS), a primary bone tumor arising from
mesenchymal cells, has the highest fatality rate of all cancers
among children and adolescents and many patients suffer
from disease recurrence due to existing or potential distant
metastasis (Ritter and Bielack, 2010). Patients with OS
may benefit novel non-conventional therapies, such as
small molecule-targeted drugs, but these strategies often
lead to severe side effects and have failed in clinical trials
(Otoukesh et al., 2018), therefore therapies focusing on complex
gene regulation axes or networks are urgently needed. An
increasing number of circRNAs that act as tumor suppressor
or onco-circRNAs deregulated in bone cancer have been
published. Below we describe the most significant studies in
terms of inclusion of exploitation of patients’ cohorts and
in vitro models.
Circular RNA hsa-circ-0016347 that derives from the KCNH1
oncogene was found to have high expression levels in
osteosarcoma tissue samples and in cell lines and to promote
proliferation, invasion and metastasis in vitro and in vivo (Jin
et al., 2017; Table 2). Zhang et al. (2017) found a circRNA
from UBAP2 gene to be the most upregulated circRNA in
osteosarcoma patient samples respect to adjacent non-tumoral
tissues. High expression of circUBAP2 correlated with lower
overall survival of the patients, promoted osteosarcoma growth
and inhibited apoptosis both in vitro and in vivo.
In OS cell lines, tissues and plasma circHIPK3 was
demonstrated to be down-regulated together with circ_001569,
ciRS-7 and circ-Foxo3 (Xiao-Long et al., 2018; Table 2).
Moreover, the authors showed that patients with lower
expression of circHIPK3 had shorter overall survival time than
those with higher circHIPK3 expression. Furthermore, they
showed that circHIPK3 expression was associated with several
clinicopathological features of patients with OS (Xiao-Long
et al., 2018; Table 2). CircHIPK3 levels were associated to
Enneking stage and lung metastasis other than age, gender and
tumor location according to statistical analysis. These results
showed that lung metastasis and advanced cancer were associated
with lower expression levels of circHIPK3 and suggested that
circHIPK3 may be used as a biomarker for diagnosis and
prognosis prediction of osteosarcoma.
CircRNAs in Muscle-Invasive Cancers
Bladder cancer is the most common malignancy of the urinary
system and it can be classified into two types according to the
depth of cancer invasion: non-muscle invasive tumor (70–80%)
and muscle-invasive tumor (20–30%). Patients with muscle-
invasive bladder cancer (MIBC) present high incidence of
metastasis and poor prognosis. Therefore, for MIBC patients it
is urgent to find biomarkers for early diagnosis and to follow
the progression of the disease during active surveillance by liquid
biopsy (de Kruijff et al., 2020). Very recently a novel circRNA, circ
lysophosphatidic acid receptor 1 (LPAR1) (hsa_circ_0087960),
derived from two exons of 226 base pairs in length, has been
identified in MIBC tissues (Table 3). circLPAR1 was found
to be expressed at low level in a cohort of 125 cases of
MIBC tissues. Furthermore, it predicted a worse disease-specific
survival time than patients with high circLPAR1 expression (Lin
et al., 2019). The authors showed the circLPAR1 may function as
a potential novel biomarker for the prognosis of MIBC and may
be associated with invasion and metastasis (Lin et al., 2019).
For an overview of the various circRNAs that have been
found expressed in the various solid tumors as bladder
cancer, breast cancer, colorectal carcinoma, esophageal squamous
cell carcinoma, hepatocellular carcinoma, gastric cancer, lung
and ovarian cancer, skin cancer, see the comprehensive
review by Kristensen et al. (2018).
CircRNAs IN CANCER STEM CELLS
cancer stem cells are a small proportion of cells considered the
driving force of tumor initiation, progression, chemoresistance,
relapse, and are also responsible for metastatic dissemination and
therapeutic failure. By definition, both CSCs and normal tissue
stem cells possess self-renewal capacity, however, in CSCs self-
renewal is typically deregulated. Several lines of evidence have
suggested that circRNAs might contribute to the stemness of
cancer and to the resistance of cancer cells to chemotherapy.
Recently, many studies have demonstrated that circRNAs may
be stably expressed and present in relatively high quantities in
human body fluids, such as saliva, plasma, serum and exosomes,
which also makes circRNAs ideal candidates as non-invasive
liquid biopsy biomarkers for cancer (Su et al., 2019).
Increasing evidence obtained analyzing circRNA/miRNA
network by bioinformatics approaches has established that
specific circRNAs are implicated in stemness via serving as
miRNA sponges in different cancers, such as breast cancer (Yan
et al., 2017), laryngeal cancer (Wu Y. et al., 2018), gastric
cancer (Zhao X. et al., 2020), and hepatocellular carcinoma
(Zhu et al., 2019). As for glioma, since circPTN was shown to
sponge miR-145-5p, which is a negative regulator of stemness
(Zhao X. et al., 2020) and self-renewal (Rani et al., 2013)
and since circPTN expression was more than 10-fold higher
in glioma cells compared with normal glial cells, Chen J.
et al. (2019) hypothesized that circPTN may be a positive
regulator of stemness. As expected, tumor sphere formation
assays determined that circPTN promoted increased levels of
stemness markers, such as Nestin, CD133, SOX2, and SOX9,
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and tumor growth in vitro and in vivo, primarily via sponging
miR-145-5p/miR-330-5p (Chen J. et al., 2019).
Interestingly, a recent study showed that exosomes from
CD133+ cells carrying circ-ABCC1 mediate cell stemness and
metastasis in colorectal cancer, revealing that circ-ABCC1 may
be used as a biomarker in CRC studies (Zhao H. et al., 2020).
In addition, the stem transcription factors upregulated by
specific circRNAs can acts as positive regulators of circRNAs
themselves, as revealed for SNAIL. It is a key transcription
factor regulating many processes in tumor biology, such as the
epithelial mesenchymal transition (EMT) and the induction and
regulation of cancer stem cells. SNAIL is regulated by signaling
networks involving plenty of ncRNAs, including circRNAs,
which usually act as sponges for miRNAs targeting SNAIL.
For example, in hepatocellular carcinoma (HCC), circ-ZNF652
is significantly upregulated and linked to highly metastatic
features and poor prognosis, it physically interacts with miR-
203 and miR-502-5p as a sponge to increase the expression
of SNAIL. Interestingly, Snail, in turn, may also regulate circ-
ZNF652 through physically binding to the E-box motif on
the promoter of circ-ZNF652 to increase its expression. This
loop thus forms a positive feedback that perpetuates the circ-
ZNF652/miR-203/502-5p/Snail signaling axis (Guo et al., 2019;
Skrzypek and Majka, 2020).
CONCLUSION
Circular RNAs are emerging as an extremely relevant class of
endogenous RNAs expressed abundantly by the transcriptome.
They are characterized by a covalently closed loop structure,
resulting in RNA molecules that are more stable than linear
RNAs. Thanks to these molecular structural features, they are
suitable to be considered excellent biomarkers for the diagnosis
and prognosis in cancer disease using liquid biopsy techniques.
High-throughput sequencing technologies are revealing
an increasing number of circRNAs in all human organs
and systems, the deregulation of which is a very
important source of knowledge because it can be exploited
for the early diagnosis and/or for the prediction of
the outcome in some tumors. The implementation of
specific bioinformatic tools makes possible to predict the
cellular functions of circRNAs in physiological conditions
and in diseases.
The circRNAs-microRNA code, in particular, is emerging to
have great impact on the regulation of gene expression during
development and differentiation, as well as in diverse pathologies
and cancer. The molecular stability of circRNAs provides a
great potential which renders them good tools for therapeutic
innovative strategies. Engineered circRNA delivery to cells via
exosomes could be among the most important issues in the next
years to improve the precision therapy against several diseases,
including cancer.
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